E-LIB Suche - Ergebnisse für: Flanagan, E.P.

1

Isolated recurrent myelitis in a persistent MOG positive pa..:

Anis, S. ; Regev, K. ; Pittock, S.J....
Multiple Sclerosis and Related Disorders. 30 (2019) - p. 163-164 , 2019

Link: https://doi.org/10.1016/..

2

A path to understanding autoimmuneGFAPastrocytopathy:

Zekeridou, A. ; McKeon, A. ; Flanagan, E. P.
European Journal of Neurology. 25 (2017) 3 - p. 421-422 , 2017

Link: https://doi.org/10.1111/..

3

Immunotherapy trial as diagnostic test in evaluating patien..:

Flanagan, E. P. ; Saito, Y. A. ; Lennon, V. A....
Neurogastroenterology & Motility. 26 (2014) 9 - p. 1285-1297 , 2014

Link: https://doi.org/10.1111/..

4

Amiodarone‐associated neuromyopathy: a report of four cases:

Flanagan, E. P. ; Harper, C. M. ; St Louis, E. K...
European Journal of Neurology. 19 (2012) 5 - p. , 2012

Link: https://doi.org/10.1111/..

5

Primary intramedullary spinal cord lymphoma:

Flanagan, E.P. ; O'Neill, B.P. ; Porter, A.B....
Neurology. 77 (2011) 8 - p. 784-791 , 2011

Link: https://doi.org/10.1212/..

6

Paraneoplastic isolated myelopathy: Clinical course and neu..:

Flanagan, E.P. ; McKeon, A. ; Lennon, V.A....
Neurology. 76 (2011) 24 - p. 2089-2095 , 2011

Link: https://doi.org/10.1212/..

7

P644 Body composition does not predict clinical course in p..:

Tassone, D ; Xu, E ; Winata, S H L...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1230-i1230 , 2024

Link: https://doi.org/10.1093/..

8

P1141 Global perspectives on managing Inflammatory Bowel Di..:

Casanova, M J ; Gisbert, J P ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2042-i2044 , 2024

Link: https://doi.org/10.1093/..

9

An online intervention for carers to manage behavioral symp..:

Mioshi, E. ; Grant, K. ; Flanagan, E....
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. , 2024

Link: https://doi.org/10.1080/..

10

P340 Issues on implementing treat-to-target approach in Asi..:

Akyüz, F ; An, Y K ; Aniwan, S...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i476-i478 , 2023

Link: https://doi.org/10.1093/..

11

P378 Pharmacokinetics of Vedolizumab and Ustekinumab in pre..:

Prentice, R ; Flanagan, E ; Wright, E K...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i508-i510 , 2023

Link: https://doi.org/10.1093/..

12

P683 Infliximab, adalimumab and vedolizumab levels are not ..:

Flanagan, E ; GIbson, P R ; Rosella, O..
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S556-S557 , 2020

Link: https://doi.org/10.1093/..

13

P660 Stability of serum concentrations of infliximab and ad..:

Flanagan, E ; Gibson, P R ; Ross, A..
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S449-S450 , 2019

Link: https://doi.org/10.1093/..

14

P264 Real-world Orkambi cohort CorK study (ROCK) - a prospe..:

Arooj, P. ; Morrissy, D. ; Ronan, N....
Journal of Cystic Fibrosis. 18 (2019) - p. S131-S132 , 2019

Link: https://doi.org/10.1016/..

15

P571 Vedolizumab (VDZ) real-world outcomes in ulcerative co..:

Pulusu, S S R ; Srinivasan, A ; Krishnaprasad, K...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S395-S396 , 2018

Link: https://doi.org/10.1093/..